Your browser doesn't support javascript.
loading
The Impact of Alternate Methodological and Structural Assumptions on Results of Cost-effectiveness Analysis: Empirical Evidence using Three Indian Economic Evaluations.
Sharma, Deepshikha; Aggarwal, Arun Kumar; Bahuguna, Pankaj; Prinja, Shankar.
Affiliation
  • Sharma D; Project Co-Ordinator, Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Aggarwal AK; Professor and Head, Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Bahuguna P; Economic Evaluation Specialist, Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Prinja S; Research Associate, School of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, Heath Economics and Health Technology Assessment, University of Glasgow, Glasgow, Scotland, UK.
Indian J Public Health ; 68(1): 9-14, 2024 Jan 01.
Article in En | MEDLINE | ID: mdl-38847626
ABSTRACT

BACKGROUND:

Despite advancement in methods and application of economic evaluations (EEs), there are several uncertainties.

OBJECTIVES:

To assess the impact of alternate methodological and structural assumptions for four key principles of EE, on the results of cost-effectiveness analysis. MATERIALS AND

METHODS:

Three previously published model-based EEs were used (1) Integrated Management of Neonatal and Childhood Illnesses (IMNCIs) intervention; (2) intervention for multiple myeloma, and (3) safety-engineered syringes (SES) intervention. A series of empirical analyses was undertaken to assess the impact of alternate assumptions for discount-rate, time-horizon, study perspective, and health outcome measure, on incremental cost-effectiveness ratio (ICER), and interpretation of cost-effectiveness.

RESULTS:

Increasing discount rate resulted in an increase in ICERs, for all three case-studies; however, there was no change in the conclusions. Using shorter time-horizons resulted in a significant increase in ICERs, the multiple myeloma intervention remained cost-ineffective, SES intervention became cost-ineffective, whereas IMNCI intervention remained cost-effective, despite a three-fold increase in ICER. On using disability adjusted life years instead of quality adjusted life years, ICERs increased to 0.04, 2 and 4 times for SES, IMNCI and multiple myeloma interventions, respectively. On analyzing results from a societal perspective, a decline in ICERs was observed. The decline was significant for IMNCI where the intervention turned dominant/cost-saving. In the other two case-studies decline in ICERs was modest, 32% for multiple myeloma, and 4% for SES.

CONCLUSION:

We observed a significant impact of using alternate assumptions on ICERs which can potentially impact resource-allocation decisions. Our findings provide strong argument in favor of standardization of processes and development of country-specific guidelines for conduct of EE.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cost-Benefit Analysis / Multiple Myeloma Limits: Humans Country/Region as subject: Asia Language: En Journal: Indian J Public Health Year: 2024 Type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cost-Benefit Analysis / Multiple Myeloma Limits: Humans Country/Region as subject: Asia Language: En Journal: Indian J Public Health Year: 2024 Type: Article Affiliation country: India